Literature DB >> 9579823

Putative markers for the detection of breast carcinoma cells in blood.

E M Eltahir1, D S Mallinson, G D Birnie, C Hagan, W D George, A D Purushotham.   

Abstract

The aim of this study was to investigate certain genes for their suitability as molecular markers for detection of breast carcinoma cells using the reverse transcriptase-polymerase chain reaction (RT-PCR). RNA was prepared from MCF-7 breast carcinoma cells and peripheral blood leucocytes of healthy female volunteers. This RNA was screened for mRNA of MUC1, cytokeratin 19 (CK19) and CD44 (exons 8-11) by RT-PCR and the results validated by Southern blots. Variable degrees of expression of MUC1 and CD44 (exons 8-11) were detected in normal peripheral blood, rendering these genes non-specific for epithelial cells and therefore unsuitable for use as markers to detect breast carcinoma cells. Although CK19 mRNA was apparently specific, it was deemed unsuitable for use as a marker of breast cancer cells in light of its limited sensitivity. Furthermore, an attempt at using nested primers to increase sensitivity resulted in CK19 mRNA being detected after two amplification rounds in blood from healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579823      PMCID: PMC2150149          DOI: 10.1038/bjc.1998.203

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Illegitimate transcription: transcription of any gene in any cell type.

Authors:  J Chelly; J P Concordet; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.

Authors:  H de Graaf; G M Maelandsmo; P Ruud; A Forus; T Oyjord; O Fodstad; E Hovig
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

Review 3.  The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

Authors:  R Moll; W W Franke; D L Schiller; B Geiger; R Krepler
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

4.  Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.

Authors:  M Yamada; R Wasserman; B Lange; B A Reichard; R B Womer; G Rovera
Journal:  N Engl J Med       Date:  1990-08-16       Impact factor: 91.245

5.  Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.

Authors:  B Smith; P Selby; J Southgate; K Pittman; C Bradley; G E Blair
Journal:  Lancet       Date:  1991-11-16       Impact factor: 79.321

6.  Detection of malignant bone tumors: MR imaging vs scintigraphy.

Authors:  J A Frank; A Ling; N J Patronas; J A Carrasquillo; K Horvath; A M Hickey; A J Dwyer
Journal:  AJR Am J Roentgenol       Date:  1990-11       Impact factor: 3.959

7.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells.

Authors:  U Günthert; M Hofmann; W Rudy; S Reber; M Zöller; I Haussmann; S Matzku; A Wenzel; H Ponta; P Herrlich
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

8.  Significance of CD44 gene products for cancer diagnosis and disease evaluation.

Authors:  Y Matsumura; D Tarin
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

9.  Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.

Authors:  I J Diel; M Kaufmann; R Goerner; S D Costa; S Kaul; G Bastert
Journal:  J Clin Oncol       Date:  1992-10       Impact factor: 44.544

10.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

View more
  13 in total

Review 1.  The detection of circulating breast cancer cells in blood.

Authors:  A M Gilbey; D Burnett; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

2.  High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood.

Authors:  K J Martin; E Graner; Y Li; L M Price; B M Kritzman; M V Fournier; E Rhei; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

3.  Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.

Authors:  William E Gillanders; Kaidi Mikhitarian; Renee Hebert; Patrick D Mauldin; Yuko Palesch; Christian Walters; Marshall M Urist; G Bruce Mann; Gerard Doherty; Virginia M Herrmann; Arnold D Hill; Oleg Eremin; Mohamed El-Sheemy; Richard K Orr; Alvaro A Valle; Michael A Henderson; Robert L Dewitty; Sonia L Sugg; Eric Frykberg; Karen Yeh; Richard M Bell; John S Metcalf; Bruce M Elliott; Thomas Brothers; Jay Robison; Michael Mitas; David J Cole
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

4.  Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.

Authors:  C Matuschek; Edwin Bölke; G Lammering; P A Gerber; M Peiper; W Budach; H Taskin; H B Prisack; G Schieren; K Orth; H Bojar
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

5.  Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients.

Authors:  E Bölke; K Orth; P A Gerber; G Lammering; R Mota; M Peiper; C Matuschek; W Budach; E Rusnak; S Shaikh; B Dogan; H B Prisack; H Bojar
Journal:  Eur J Med Res       Date:  2009-08-12       Impact factor: 2.175

6.  Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.

Authors:  D Masson; M G Denis; P Lustenberger
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

7.  Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma.

Authors:  T Kuroki; T Tomioka; Y Tajima; K Inoue; Y Ikematsu; K Ichinose; J Furui; T Kanematsu
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

8.  Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer.

Authors:  A E Merrie; K Yun; J Gunn; L V Phillips; J L McCall
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.

Authors:  E Hesse; P B Musholt; E Potter; T Petrich; M Wehmeier; R von Wasielewski; R Lichtinghagen; T J Musholt
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

10.  Gene expression of circulating tumour cells in breast cancer patients.

Authors:  E Bölke; K Orth; P A Gerber; G Lammering; R Mota; M Peiper; C Matuschek; W Budach; E Rusnak; S Shaikh; B Dogan; H B Prisack; Hans Bojar
Journal:  Eur J Med Res       Date:  2009-09-28       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.